AIMS/HYPOTHESIS: Diabetes frequently develops in patients with pancreatic disorders. We aimed to determine the lower threshold of beta cell area for diabetes manifestation as well as the impact of insulin sensitivity on glucose homoeostasis in patients with pancreatic diabetes. METHODS: Eighty-two patients undergoing pancreatic surgery underwent pre-operative oral glucose challenge. Fractional pancreatic beta cell area was determined, and indices of insulin sensitivity and beta cell function were calculated. RESULTS: HbA1c and glucose levels were similar in patients with high and intermediate beta cell area, but were significantly higher in those with the lowest beta cell area (p < 0.0001). Insulin secretion was reduced only in patients with the lowest beta cell area (p < 0.001). The relative beta cell deficits at the onset of diabetes and impaired glucose tolerance were 64% and 21%, respectively, based on 2 h glucose levels. Deteriorating insulin sensitivity was associated with a small increase in the incidence of diabetes. CONCLUSIONS/ INTERPRETATION: In conclusion, pancreatic diabetes probably develops after a reduction in beta cell area of ~65%. Post-challenge glucose excursions are much more closely related to pancreatic beta cell area than to fasting glycaemia, thereby underlining the usefulness of the OGTT in patients with pancreatic disorders.
AIMS/HYPOTHESIS: Diabetes frequently develops in patients with pancreatic disorders. We aimed to determine the lower threshold of beta cell area for diabetes manifestation as well as the impact of insulin sensitivity on glucose homoeostasis in patients with pancreatic diabetes. METHODS: Eighty-two patients undergoing pancreatic surgery underwent pre-operative oral glucose challenge. Fractional pancreatic beta cell area was determined, and indices of insulin sensitivity and beta cell function were calculated. RESULTS: HbA1c and glucose levels were similar in patients with high and intermediate beta cell area, but were significantly higher in those with the lowest beta cell area (p < 0.0001). Insulin secretion was reduced only in patients with the lowest beta cell area (p < 0.001). The relative beta cell deficits at the onset of diabetes and impaired glucose tolerance were 64% and 21%, respectively, based on 2 h glucose levels. Deteriorating insulin sensitivity was associated with a small increase in the incidence of diabetes. CONCLUSIONS/ INTERPRETATION: In conclusion, pancreatic diabetes probably develops after a reduction in beta cell area of ~65%. Post-challenge glucose excursions are much more closely related to pancreatic beta cell area than to fasting glycaemia, thereby underlining the usefulness of the OGTT in patients with pancreatic disorders.
Authors: Riccardo C Bonadonna; Tim Heise; Christophe Arbet-Engels; Christoph Kapitza; Angelo Avogaro; Joe Grimsby; Jay Zhi; Joseph F Grippo; Raffaella Balena Journal: J Clin Endocrinol Metab Date: 2010-08-25 Impact factor: 5.958
Authors: Y Saisho; A E Butler; E Manesso; R Galasso; L Zhang; T Gurlo; G M Toffolo; C Cobelli; K Kavanagh; J D Wagner; P C Butler Journal: Diabetologia Date: 2009-10-22 Impact factor: 10.122
Authors: Peter In't Veld; Dirk Lievens; Joeri De Grijse; Zhidong Ling; Bart Van der Auwera; Miriam Pipeleers-Marichal; Frans Gorus; Daniel Pipeleers Journal: Diabetes Date: 2007-06-11 Impact factor: 9.461
Authors: Juris J Meier; Bjoern A Menge; Thomas G K Breuer; Christophe A Müller; Andrea Tannapfel; Waldemar Uhl; Wolfgang E Schmidt; Henning Schrader Journal: Diabetes Date: 2009-06-09 Impact factor: 9.461
Authors: Christopher Faulk; Kate R Mueller; David Cheishvili; Mathia Colwell; Anne-Sophie Pepin; Moshe Syzf; Bernhard J Hering; Christopher Burlak Journal: Xenotransplantation Date: 2020-01-26 Impact factor: 3.907
Authors: Nathaniel J Hart; Radhika Aramandla; Gregory Poffenberger; Cody Fayolle; Ariel H Thames; Austin Bautista; Aliya F Spigelman; Jenny Aurielle B Babon; Megan E DeNicola; Prasanna K Dadi; William S Bush; Appakalai N Balamurugan; Marcela Brissova; Chunhua Dai; Nripesh Prasad; Rita Bottino; David A Jacobson; Mitchell L Drumm; Sally C Kent; Patrick E MacDonald; Alvin C Powers Journal: JCI Insight Date: 2018-04-19